Search research articles
Contact Us
Filters
Showing results (771-780 of 839) with videos related to
Page
of 84
Sort By:
JAMA Oncology
|
May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
Cancer Research
|
September 8, 2022
Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers
Robert B Scharpf, Archana Balan, Biagio Ricciuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer
B Ricciuti, S Scalera, X Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2025
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
Seshiru Nakazawa, Federica Pecci, Biagio Ricciuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
A Cortellini, B Ricciuti, F Facchinetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung Cancer
Magda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2018
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
J K Sabari, G C Leonardi, C A Shu, et al.
Science (New York, N.Y.)
|
November 15, 2014
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S Crystal, Alice T Shaw, Lecia V Sequist, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Circulation. Heart Failure
|
May 14, 2025
Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence
James M Hillis, Bernardo C Bizzo, Sarah F Mercaldo, et al.
Page
of 84
Search research articles
Search
Showing results (771-780 of 839) with videos related to
Sort By:
Page
of 84
JAMA Oncology
|
May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
Cancer Research
|
September 8, 2022
Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers
Robert B Scharpf, Archana Balan, Biagio Ricciuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer
B Ricciuti, S Scalera, X Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2025
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
Seshiru Nakazawa, Federica Pecci, Biagio Ricciuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
A Cortellini, B Ricciuti, F Facchinetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung Cancer
Magda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2018
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
J K Sabari, G C Leonardi, C A Shu, et al.
Science (New York, N.Y.)
|
November 15, 2014
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S Crystal, Alice T Shaw, Lecia V Sequist, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Circulation. Heart Failure
|
May 14, 2025
Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence
James M Hillis, Bernardo C Bizzo, Sarah F Mercaldo, et al.
Page
of 84